U.S., March 21 -- ClinicalTrials.gov registry received information related to the study (NCT06887556) titled 'Mpox Comprehensive Assessment for Responsive Immunisation in Emergency Outbreaks' on Feb. 18.
Brief Summary: The MPXV CARE study principally aims to use clinical and epidemiology data to target specific individuals willing and able to provide appropriate and proportionate biological samples to develop novel immune diagnostics that support models of disease burden and future vaccine utilisation.
Study Start Date: Feb. 05
Study Type: INTERVENTIONAL
Condition:
Mpox
Intervention:
DIAGNOSTIC_TEST: ELISA
Mpox-specific antibody ELISA
DIAGNOSTIC_TEST: Lateral flow assay
Dried blood spot lateral flow assay for Mpox antibody
Recrui...